Bone graft substitutes in the radius and upper limb

Journal of the American Society for Surgery of the Hand

Volumn 3, Issue 4, 2003, Pages 227-245

  Ladd, Amy L ^a,b   Pliam, Nick B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Robert A Chase Hand/Upper Limb Ctr   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BONE CEMENT; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; CALCIUM SULFATE; CHRYSALIN; COLLAGEN; FIBROBLAST GROWTH FACTOR; GELATIN; GLASS; GLYCEROL; GROWTH FACTOR; HYALURONIC ACID; INFUSE; NEOSTEO; OSSIGEL; OSTEOGENIC PROTEIN 1; POLY(METHYL METHACRYLATE); POLYGLACTIN; POLYMER; PROTEIN ANTIBODY; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SILICON DIOXIDE; THROMBIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ALLOGRAFT; ARM FRACTURE; BONE CONDUCTION; BONE GRAFT; BONE MATRIX; BONE MINERAL; BONE PROSTHESIS; BONE REMODELING; BONE STRUCTURE; BONE TRANSPLANTATION; CERAMIC PROSTHESIS; CLINICAL PRACTICE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; HUMAN; MARKETING; NONHUMAN; RADIUS FRACTURE; REVIEW; SIDE EFFECT; TREATMENT INDICATION;

EID: 0346147014     PISSN: 15310914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jassh.2003.09.007     Document Type: Article

References (66)

1. Earnshaw SA, Cawte SA, Worley A, Hosking DJ. Colle's fractures of the wrist as an indicator of underlying osteoporosis in postmenopausal women: a prospective study of bone mineral density and bone turnover rate: Osteoporosis Int 1998;8: 53-60.
2. Owen RA, Melton LJ, Johnson KA, Ilstrup DM, Riggs BL. Incidence of Colle's fracture in a North American community. Am J Public Health 1982;72:605-607.
3. Fernandez DL, Jupiter JB. Epidemiology, mechanism, clasification. In: Fernandez DL, Jupiter JB, eds. Fractures of the distal radius: a practical approach to management. New York: Springer Verlag, Inc, 1996:23-52.
4. Melone CP Jr. Distal radius fractures. Patterns of articular fragmentation. Orthop Clin North Am 1993;24:239-253.
5. Szabo RM, Weber SC. Comminuted intra-articular fractures of the distal end of the radius. Clin Orthop 1988;230:39-48.
6. Seitz WH, Froimson AI, Leb R, Shapiro JD. Augmented external fixation of unstable distal radius fractures. J Hand Surg 1991;16A:1010-1016.
7. Axelrod TS, McMurtry RY. Open reduction and internal fixation of comminuted, intra-articular fractures of the distal radius. J Hand Surg 1990;15A:1-11.
8. Medoff RJ. Fracture specific fixation system for distal radius fractures. Arch Am Acad Orthop Surg 1999;2:53-61.
9. McQueen M, Caspers J. Colles fracture: does the anatomical result affect the final function? J Bone Joint Surg 1988;70B: 649-651.
10. Segalman KA, Clark GL. Un-united fractures of the distal radius: a report of 12 cases. J Hand Surg 1998;23A:914-919.
11. Knirk JL, Jupiter JB. Intra-articular fractures of the distal end of the radius in youg adults. J Bone Joint Surg 1986;68A:647-659.
12. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma 1989;3:192-195.
13. Zhu XL, Luo C, Ferrier JM, Sodek J. Evidence of ectokinase-mediated phophorylation of osteopontin and bone sialoprotein by osteoblasts during bone formation in vitro. Biochem J 1997;323:637-643.
14. Wolff J. The law of bone transformation, 1892. (Translated by P. Maquet.) New York:Springer-Verlag, 1986.
15. FDA and AATB. Regarding demineralized bone matrix regulation. Available: http://www.fda.gov/cber/tissue/071197tp.pdf. Accessed July 11, 1997.
16. Centers for Disease Control and Prevention. Update: allograft-associated bacterial infections-United States, 2002. MMWR Morb Mortal Wkly Rep Available: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5110a2.htm. Accessed: March 15, 2002.
17. Centers for Disease Control and Prevention. Epidemiologic notes and reports transmission of HIV through bone transplantation: case report and public health recommendations. MMWR Morb Mortal Wkly Rep Available: http://www.cdc.gov/mmwr/preview/mmwrhtml/00001284.htm. Accessed: October 7, 1988.
18. Urist MR, Silverman BF, Buring K, Dubuc FL, Rosenberg JM. The bone induction principle. Clin Orthop 1967;53:243-283.
19. Bostrom MP, Yang X, Kennan M, Sandhu H, Dicarlo E, Lane JM. An unexpected outcome during testing of commercially available demineralized bone graft materials: how safe are the nonallograt components? Spine 2001;26:1425-1428.
20. Kelly CM, Wilkins RM, Gitelis S, Hartjen C, Watson JT, Kim PT. The use of a surgical grade calcium sulfate as a bone graft substitute: results of a multicenter trial. Clin Orthop 2001;382:42-50.
21. Scaglione PH, Buchman MT. Collagraft bone substitute in upper extremity fractures: a preliminary study. Surg Forum 1997;563-564.
22. Chapman MW, Bucholz R, Cornell C. Treatment of acute fractures with a collagen-calcium phosphate graft material. A randomized clinical trial. J Bone Joint Surg 1997;79A:495-502.
23. Truumees E, Herkowitz HN. Alternatives to autologous bone harvest in spine surgery. Univ Penn Orthop J 1999;12:77-88.
24. Weber KD, Brauer RN, Weiss W, Becker K. Osseous intergration of bovine hydroxyapatite ceramic in metaphyseal bone defects of the distal radius. J Hand Surg 2000;25A:833-841.
25. Shors EC. Coralline bone graft substitutes. Orthop Clin North Am 1999;30:599-613.
26. Bucholz RW, Carlton A, Holmes R. Interporous hydroxyapatite as a bone graft substitute in tibial plateau fractures. Clin Orthop 1989;240:53-62.
27. Wolfe SW, Pike L, Slade JF III, katz LD. Augmentation of distal radius fracture fixation with coralline hydroxyapatite bone graft substitute. J Hand Surg 1999;24:816-827.
28. Mathysen A. Du bandage plat̂re et de son application dans le traitment des fractures. Liege: Grandmont-Dondres, 1854.
29. Dreesman H. Ueber Knochenplombierung. Bietr Klin Chir 1892;9:804-810.
30. Peltier LF. The use of plaster of Paris to fill large defects in bone. A preliminary report. Am J Surg 1959;97:11-15.
31. FDA. proposed Rules 5753-5756. Orthopaedic Devices; Proposed Classification for the Resorbable Calcium Salt Bone Void Filler Device: Federal Register Docket # 01N-0411/Vol. 67, No. 26/Thursday, February 7, 2002. Available: http://www.fda.gov/OHRMS/DOCKETS/98fr/020702c.pdf.
32. Toth JM, An HS, Lim TH, et al. Evaluation of porous biphasic calcium phosphated ceramics for anterior cervical interbody fusion in a caprine model. Spine 1995;20:2203-2210.
33. Resnick DK. Vitoss bone substitute. Neurosurgery 2002;50: 1162-1164.
34. FDA. Chronos FDA approval 2002. Available: www.fda.gov/cdrh/pdf/k013072.pdf.
35. Hinz P, Wolf E, Schwesinger G, Hartelt E, Ekkernkamp A. A new resorbable bone void filler in trauma: early clinical experience and histologic evaluation. Orthopedics 2002; 25(suppl 5):s597-s600.
36. Constantz BR, Ison IC, Fulmer MT, Poser RD, Smith ST, Van Wagoner M. Skeletal repair by in situ formation of the mineral phase of bone. Science 1995;24:1796-1799.
37. McCalden RW, McGeough JA, Court-Brown CM. Age-related changes in the compressive strenght of cancellous bone. The relative importance of changes in density and trabecular architecture. J Bone Joint Surg 1997;79A:421-427.
38. Yetkinler DN, Ladd AL, Poser RD, Constantz BR. Carter D. Biomechanical evaluation of intraarticular distal radius fracture treatment stability: K-wires vs calcium phosphate bone cement. J Bone Joint Surg 1999;81A:391-399.
39. Vaes G. Cellular biology and biochemical mechanism of bone resorption. A review of recent developments on the formation, activation, and mode of action of osteoclasts. Clin Orthop 1988;231:239-271.
40. Frankenburg EP, Goldstein SA, Bauer TW, Harris SA, Poser RD. Biomechanical and histological evaluation of a calcium phosphate cement. J Bone Joint Surg 1998;80A:1112-1124.
41. Jupiter JB, Winters S, Sigman S, et al. Repair of five distal radius fractures with an investigational cancellous bone cement: a preliminary report. J Orthop Trauma 1997;11:110-116.
42. Cassidy C, Jupiter JB, Cohen M, et al. Norian SRS vs conventional therapy in distal radius fractures: multicenter study pf 323 patients. J Bone Joint Surg (in press).
43. Norian SRS. FDA panel transcript. Document #3463t2.pdf. Available: http://www.fda.gov/ohrms/dockets/ac/cdrh98t.htm#. Orthopedic and Rehabilitation Devices Panel. Accessed: October 9, 1998.
44. Dickson KF, Friedman J, Buchholz JG, Flandry FD. The use of BoneSource hudroxyapatite cement for traumatic metaphyseal bone void filling. J Trauma 2002;53:1103-1108.
45. Knaack D, Goad ME, Aiolova M, et al. Resorbable calcium phosphate bone substitute. J Biomed Mater Res 1998;43: 399-409.
46. Hench LL, Paschall HA. Histochemical responses at a biomaterials interface. J Biomed Mater Res 1974;5:49-54.
47. Oonishi H, Kushitani S, Yasukawa E, et al. Particulate bio-glass compared with hydroxyapatite as a bone graft substitute. Clin Orthop 1997;334:316-325.
48. Charnley J. The healing of human fractures in contact with self-curing acrylic cement. Clin Orthop 1966;47:157-163.
49. Cytokines. In: Goldsby RA, Kindt TJ, Osborne BA, eds. Kuby Immunology. 4th ed. New York: WH Freeman Co, 2000.
50. Blobe GC, Scheimann WP, Loish HF. Role of transforming growth factor β in human disease. N Engl J Med 2000;342:1350-1358.
51. Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg 2002;84A:1032-1044.
52. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002;297:2256-2259.
53. Muschler GF, Nitto H, Boehm CA, Easley KA. Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res 2001;19:117-125.
54. Muschler GF, Midura RJ. Connective tissue progenitors: practical concepts for clinical application. Clin Orthop 2002; 395:66-80.
55. Weibrich G, Kleis WK, Hafner G, Hitzler WE. Growth factor levels in platelet-rich plasma and correlations with donor age, sex and platelet count. J Craniomaxillofac Surg 2002;30:97-102.
56. Li H, Zou Xue Q, Egund N, Lind M, Bunger C. Anterior lumbar interbody fusion with brantigan cages loaded with bioceramics and platelet rich plasma. Orthop Res Trans 2003; 28:265.
57. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg 2001;83A (Suppl 1):S151-S158.
58. Boden SD, Kang J, Sandhu H, Heller JG. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine 2002;27:2662-2673.
59. FDA. Safety and efficacy of INFUSE. Available: http://www.fda.gov/cdrh/pdf/P000058b.pdf. Accessed: July 2, 2002.
60. Boden SD. Bioactive factors for bone tissue engineering. Clin Orthop 1999;367(Suppl):S84-S94.
61. Street J, Bao , deGuzman L, et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 2002;99:9656-9661.
62. Bouletreau PJ, Warren SM, Spector JA, Steinbrech DS, Mehrara BJ, Longaker MT. Factors in the fracture microenvironment induce primary osteoblast angiogenic cytokine production. Plast Reconstr Surg 2002;110:139-148.
63. Norfleet AM, Huang Y, Sower LE, Redin WR, Fritz RR, Carney DH. Thrombin peptide TP508 accelerates closure of dermal excisions in animal tissue with surgically induced ischemia. Wound Repair Regen 2000;8:517-529.
64. Levine BP, Ward WA, Bramlet D, Ladd AL. Phase I/II evaluation of a thrombin-related peptide for acceleration of distal radius fracture healing. Poster exhibit, 2002 American Society for Surgery of the Hand Annual Meeting, Phoenix, AZ.
65. Ladd AL, Pliam NB. The use of bone graft substitutes in distal radius fractures. J Am Acad Orthop Surg 1999;7:279-290.
66. Ladd AL, Pliam NB. The role of bone graft and alternatives in unstable distal radius fracture treatment. Orthop Clin North Am 2001;30:337-351.